We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
+14%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$6.32B
AUM Growth
+$1.48B
Cap. Flow
+$880M
Cap. Flow %
13.91%
Top 10 Hldgs %
70.14%
Holding
41
New
6
Increased
12
Reduced
7
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 18.67%
2 Industrials 14.9%
3 Communication Services 14.1%
4 Real Estate 13.07%
5 Energy 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$1.07B 16.86%
+4,245,400
New +$1.05B
SPR
2
DELISTED
Spirit AeroSystems
SPR
$620M 9.8%
7,974,092
+513,410
+7% +$35.5M
FCE.A
3
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$593M 9.38%
23,251,035
-334,700
-1% -$8.19M
NFLX icon
4
Netflix
NFLX
$307B
$427M 6.75%
23,536,210
-1,908,390
-8% -$33.3M
ITRI icon
5
Itron
ITRI
$4.6B
$353M 5.58%
4,558,387
BIDU icon
6
Baidu
BIDU
$36.3B
$329M 5.2%
1,327,435
-304,403
-19% -$66.4M
GWPH
7
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$303M 4.79%
2,988,019
+493,281
+20% +$52.8M
JCI icon
8
Johnson Controls International
JCI
$85.3B
$267M 4.23%
6,638,393
+750,657
+13% +$30.4M
JD icon
9
JD.com
JD
$44B
$244M 3.85%
6,378,430
+152,756
+2% +$6.54M
SRC
10
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$234M 3.7%
6,083,762
+1,333,536
+28% +$49.3M
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$204M 3.23%
16,115,689
+807,546
+5% +$10.3M
ACOR
12
DELISTED
Acorda Therapeutics
ACOR
$200M 3.17%
70,623
+10,424
+17% +$27.5M
TVTX icon
13
Travere Therapeutics
TVTX
$5.26B
$166M 2.62%
6,659,166
+686,055
+11% +$15.1M
CNMD icon
14
CONMED
CNMD
$1.3B
$146M 2.3%
2,774,045
TMH
15
DELISTED
Team Health Holdings Inc
TMH
$145M 2.3%
3,338,649
AAAP
16
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$128M 2.02%
1,889,143
+818,980
+77% +$39.8M
VST icon
17
Vistra
VST
$48.5B
$121M 1.91%
6,461,525
+137,515
+2% +$2.37M
PAGP icon
18
Plains GP Holdings
PAGP
$5.28B
$118M 1.87%
+5,415,491
New +$129M
OPTU
19
Optimum Communications Inc
OPTU
$301M
$110M 1.75%
4,044,289
+414,549
+11% +$12.6M
CNX icon
20
CNX Resources
CNX
$4.91B
$107M 1.69%
7,549,765
-82,109
-1% -$1.05M
ISBC
21
DELISTED
Investors Bancorp, Inc.
ISBC
$91.4M 1.44%
+6,698,569
New +$88.4M
TRGP icon
22
Targa Resources
TRGP
$57B
$90.2M 1.43%
1,907,251
-23,341
-1% -$1.06M
FNF icon
23
Fidelity National Financial
FNF
$14.7B
$77.5M 1.23%
2,351,369
-1,821,759
-44% -$59.6M
WFT
24
DELISTED
Weatherford International plc
WFT
$64.6M 1.02%
+14,103,339
New +$58.3M
EFX icon
25
Equifax
EFX
$22B
$55.3M 0.87%
+521,624
New +$69M

Similar funds

Scopia Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Scopia Capital Management held 41 positions worth $6.32B, up 30% from $4.85B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Scopia Capital Management deployed $880M of net new capital in Q3 2017, opening 6 new positions and adding to 12 existing holdings. Its largest new stake was Plains GP Holdings: 5,415,491 shares worth $118M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was NeuroDerm Ltd. Ordinary Shares, an estimated $154M trimmed.

  • Scopia Capital Management's largest Q3 2017 buy was Plains GP Holdings: 5,415,491 shares worth $118M.
  • Scopia Capital Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q3 2017, an estimated $52.8M increase.
  • Scopia Capital Management's biggest Q3 2017 reduction was NeuroDerm Ltd. Ordinary Shares, cutting an estimated $154M.
  • Scopia Capital Management fully exited Conduent in Q3 2017, selling an estimated $111M.
  • Scopia Capital Management's ten largest holdings make up 70% of its $6.32B portfolio in Q3 2017.
  • Scopia Capital Management opened 6 new positions and closed 9 in Q3 2017.
  • Scopia Capital Management's portfolio value rose 30% quarter-over-quarter to $6.32B.

Based on Scopia Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.